Tuesday, 02 January 2024 12:17 GMT

China Cardiac Rhythm Management Devices Market Poised For Growth Through 2036 As Demand Rises For CRT, Icds And Pacemakers


(MENAFN- GlobeNewsWire - Nasdaq) China's cardiac rhythm device market offers opportunities across CRT, ICDs and pacemakers, with competitive and distribution insights supporting market entry, expansion and investment.

Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "China Cardiac Rhythm Management Devices Market Outlook to 2036 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers" has been added to ResearchAndMarkets.com's offering.

China Cardiac Rhythm Management Devices Market Outlook to 2036

The "China Cardiac Rhythm Management Devices Outlook to 2036" provides comprehensive market intelligence covering the performance, competitive landscape and long-term development of China's cardiac rhythm management devices market. Designed to support strategic decision-making, the databook delivers annualized revenue, unit volume and average selling price data across major product segments from 2024 through 2036.

The report examines three core segments: Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and pacemakers. Detailed segment-level data enables medical device manufacturers, healthcare companies, investors and other market participants to evaluate commercial opportunities, compare product category performance and identify areas with strong growth potential.

Key Market Data and Analysis

The China cardiac rhythm management devices market report includes historical and forecast data for revenues in US dollars, sales volumes in units and average prices in US dollars. These metrics are presented annually for each covered market segment, giving decision-makers a consistent framework for assessing demand, pricing trends and expected market development through 2036.

  • Annualized market revenue data by cardiac rhythm management device segment.
  • Unit volume estimates and forecasts covering the period from 2024 to 2036.
  • Average selling price analysis for CRT devices, ICDs and pacemakers.
  • 2025 company share data for the China cardiac rhythm management devices market.
  • Global corporate profiles of leading companies active in the Chinese market.
  • Available information on pipeline products, corporate news, partnerships and transactions.

Market Segmentation

The report provides focused analysis of the following China cardiac rhythm management devices market segments:

  • Cardiac Resynchronisation Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICD)
  • Pacemakers

By presenting comparable value, volume and pricing data across these categories, the databook helps users assess the relative size and future prospects of each segment. The analysis also supports benchmarking of product portfolios and evaluation of shifts in the competitive environment.

Competitive and Corporate Intelligence

Company share data for 2025 offers insight into the competitive structure of the China cardiac rhythm management devices industry. Corporate-level profiles provide additional perspective on key participants, their market presence and relevant business activities. Where data is available for the country and product category, the report also covers pipeline developments, strategic agreements, transactions and notable company news.

Reasons to Buy

  • Develop business strategies based on market segments expected to demonstrate strong future growth.
  • Support market-entry and geographic or portfolio expansion planning in China.
  • Assess the competitive landscape and understand the relative positioning of leading companies.
  • Build investment strategies using segment-level revenue, volume and pricing forecasts.
  • Identify potential commercial opportunities across CRT, ICD and pacemaker categories.
  • Evaluate key distribution channels and preferred approaches to product distribution.
  • Benchmark market performance using standardized annual data through 2036.

The "China Cardiac Rhythm Management Devices Outlook to 2036" equips stakeholders with structured, decision-ready intelligence for strategic planning, investment assessment, competitive analysis and commercial development. Its combination of market forecasts, company shares, pricing metrics and corporate intelligence provides a detailed view of one of the healthcare sector's important medical device markets

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Abbott Laboratories
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • MicroPort Scientific Corp

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14092026004107003653ID1111661646



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story